Abhishek Shah

Abhishek Shah is the current CEO at Wellthy Therapeutics. Prior to this, they were an investor at Medios Technologies from February 2019 to February 2020, when the company was acquired by Remidio Technologies. Shah also has experience as the co-founder and CEO of Meddo Health, as well as the founder of Bizly. In addition, they have worked as the CEO of myUpchar.com and Wellthy Therapeutics, and the COO of InnerChef. Before their current role, Shah held positions at SilverPush, Marvel Drugs, and Raman & Weil.

Abhishek Shah has a Master of Business Administration (M.B.A.) from the Indian School of Business, where they studied finance, strategy, and leadership. Abhishek also has a Master of Business Administration (MBA) from HKUST, where they studied finance and general business. Their undergraduate degrees are in Chemical & Biomolecular Engineering from the Georgia Institute of Technology and UCL. Abhishek also has a HSC from Jai Hindu jobs and an ICSE from Bombay Scottish School, Mumbai.

Some direct reports include Pratik Patil - Manager Strategy, Malvika Sharma - AVP - Business Development, and Aradh Pillai - VP - Design and Engineering.